IRIS
CACCIOLA, Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.655
EU - Europa 4.415
AS - Asia 4.295
SA - Sud America 1.017
AF - Africa 201
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 21.603
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.137
SG - Singapore 2.075
CN - Cina 1.586
IE - Irlanda 1.328
UA - Ucraina 1.259
BR - Brasile 903
IT - Italia 700
CA - Canada 463
RU - Federazione Russa 352
DE - Germania 183
VN - Vietnam 173
SE - Svezia 126
GB - Regno Unito 110
KR - Corea 109
CI - Costa d'Avorio 105
IN - India 94
FR - Francia 59
CH - Svizzera 55
NL - Olanda 46
AR - Argentina 41
UZ - Uzbekistan 40
FI - Finlandia 36
PL - Polonia 35
MX - Messico 31
BD - Bangladesh 30
TR - Turchia 24
JP - Giappone 23
EC - Ecuador 22
ZA - Sudafrica 22
AT - Austria 18
GR - Grecia 17
CZ - Repubblica Ceca 16
NG - Nigeria 16
IQ - Iraq 15
LB - Libano 15
EG - Egitto 14
ES - Italia 14
SN - Senegal 14
BE - Belgio 13
CO - Colombia 13
ID - Indonesia 13
RO - Romania 13
SA - Arabia Saudita 13
VE - Venezuela 13
TW - Taiwan 12
BG - Bulgaria 11
PK - Pakistan 10
MA - Marocco 9
EU - Europa 8
HK - Hong Kong 8
PE - Perù 8
AU - Australia 7
JO - Giordania 7
PY - Paraguay 7
TT - Trinidad e Tobago 7
IR - Iran 6
DZ - Algeria 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
LY - Libia 5
PT - Portogallo 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
LT - Lituania 4
UY - Uruguay 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CL - Cile 3
KE - Kenya 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
KW - Kuwait 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
RS - Serbia 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 21.595
Salva come PNG Salva come JPEG
Città #
Dallas 2.532
Dublin 1.324
Jacksonville 1.223
Singapore 1.196
Santa Clara 1.166
Chandler 959
Ashburn 670
Boardman 527
Nanjing 424
Andover 368
Cambridge 361
Lawrence 354
Toronto 353
Hefei 247
San Mateo 230
Des Moines 201
Chicago 187
Wilmington 144
Catania 139
Nanchang 123
Beijing 113
Seoul 108
Abidjan 105
Hebei 98
Shenyang 96
Los Angeles 89
Saint Petersburg 84
Grafing 77
Ottawa 76
Jiaxing 75
Civitanova Marche 73
São Paulo 70
Changsha 68
Tianjin 66
Ho Chi Minh City 54
Council Bluffs 41
New York 35
Moscow 34
Rio de Janeiro 34
Dong Ket 30
Hanoi 29
Bremen 28
Seattle 27
Milan 25
Norwalk 25
Washington 25
Munich 24
San Francisco 24
Warsaw 23
Den Haag 22
Kunming 22
Phoenix 22
Pune 21
Palermo 20
Brooklyn 19
Hangzhou 19
Liberty Lake 19
Tokyo 19
Ann Arbor 18
Belo Horizonte 18
Brasília 17
Curitiba 17
Tashkent 17
Abuja 16
Helsinki 16
Houston 16
Quito 15
Boston 14
Dakar 14
Jinan 14
Johannesburg 14
Ningbo 14
The Dalles 14
Atlanta 13
Augusta 13
Brussels 13
Columbus 13
Kochi 13
Montreal 13
Mumbai 12
Rome 12
Florence 11
Hanover 11
Lappeenranta 11
Porto Alegre 11
Redwood City 11
Stockholm 11
Amsterdam 10
Istanbul 10
Charlotte 9
Dhaka 9
Frankfurt Am Main 9
Lanzhou 9
Leawood 9
Manaus 9
Princeton 9
Taipei 9
Zhengzhou 9
Baghdad 8
Buenos Aires 8
Totale 15.086
Salva come PNG Salva come JPEG
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 441
B-linfociti CALLA (CD10) positivi nella leucemia linfatica cronica. 162
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 146
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 141
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis. 133
Thrombotic risk stratification in patients with prefibrotic myelofibrosis 119
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 119
Activation of coaugulation and fibrinolysis in laparoscopic surgery 114
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 107
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 105
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 104
A rare case of myeloid sarcoma presenting as anal fissure. 104
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 101
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 99
Phase II randomized clinical trial comparing ropeginterferon versus phlebotomy in low-risk patients with polycythemia vera. Results of the pre-planned interim analysis. 98
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 97
Activation coagulation and fibrinolysis in laparoscopic surgery 97
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 97
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untrated patients with chronic lymphocytic leukemia. 96
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 96
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 95
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 92
Abnormal Erytropoietin serum levels in acute leukemia could have a role in the pathophysiology of disease. 90
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 90
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 90
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 89
Activation of coagulation anf fibrinolysis in laparoscopic surgery 88
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 87
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 86
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 86
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 85
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 84
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 84
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 83
Is it Still Reasonable to Raise Doubts on Laparoscopic Splenectomy? 83
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 83
Idiopathic intramural hematoma of the right colon. A case report and review of the literature. 82
Long-term results after splenectomy in adult idiopathic thrombocitopenic purpura: comparison between open and laparoscopic procedures 81
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 81
Low dose of ARA-C in chronic myeloid leukemia in blastic transformation 80
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 80
How to prevent intraoperative risks and complications in laparoscopic splenectomy 80
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 80
The use of surgical drains in laparoscopic splenectomies. Consideration on a large series of 117 consecutive cases 80
Laparoscopic splenectomy: a single center experience 79
All-trans retinoic acid might also induce apoptosis in freshly isolated chro- nic myeloid leukemia cells 78
The Antiphospholipid Syndrome 78
I disordini dell'emostasi nelle emopatie maligne. 77
The antiphospholipid syndrome in pregnancy: a review article 77
In vitro sensitivity of B-CLL cells to Fludarabine and Interferons 77
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS. 76
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 76
Alteration of endothelium-coagulative system during COPD exacerbations 76
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 76
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 76
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 75
Acute lymphoblastic leukemia in elderly. 75
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 75
Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings. 74
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 74
Unusual onset of severe varicella in adult immunocompromised patients 74
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 74
B- chronic lymphocytic lekemia cells forming rosettes with sheep erythrocytes 74
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 74
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 73
Alpha interferon as a first line therapy for angioimmunoblastic lympho- adenopathy. Possible value of DR+ cells in monitoring therapeutical re- sponse. 73
Laparoscopic splenectomy reduces the need of platelet transfusion in patients operated on for idiopathic thrombocytopenic purpura 73
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 73
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 72
Le anemie carenziali. 72
Trattamento preoperatorio con interleuchina-2 nel carcinoma colorettale. 72
Immunomodulating treatment in patients with aplastic anemia. 72
Factor-VIII-rela- ted antigen and vasculitis. 72
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 72
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 72
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 72
T-subset abnormalities in Thalassemia intermedia: Possible evidence for a Thymus functional deficiency. 72
Acquired antithrombin III deficency in sickle cell disease/beta plus thalas- semia. 72
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 71
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta Thalassemia: a pilot study. 70
Thymostimulin in aplastic anaemia. 70
ECLAP Cooperative Group. A Randomized Trial. 69
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 69
Cessazione del fumo di sigaretta e riduzione dei livelli plasmatici di fattore di von Willebrand (vWF) 69
Il mitoxantrone in polichemioterapia associato allo schema CVP nel trat- tamento dei linfomi non hodgkin. 69
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 68
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 68
MECCANISMO DI ATTIVAZIONE PIASTRINICA NELLA TROMBOCITEMIA ESSENZIALE: RUOLO DEGLI ANTICORPI ANTI CELLULA ENDOTELIALE (AACE) 67
Cutaneous vasculitis in non Hodgkin's Lymphoma. 67
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis 67
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 67
Serum overexpresion of interleukin-15 in patients with essential thrombocythemia: which significance? 67
Low-dose cytarabine in myelodisplastic syndromes and acute leukemia: a comment 66
"In vitro" hyperresponsivity of diabetic platelets to "saturated" platelet-activating factor (PAF). 66
Surgical management of hereditary spherocytosis Current strategies 66
Thymostimulin in aplastic anaemia and idiopathic thrombocytopenia. 65
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neolpasms 65
JAK2V6176F mutation status and thrombosis in essential thrombocytemia 65
Interleukin-8 levels in patients with essential thrombocythemia. 65
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 64
Totale 8.622
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.400 0 0 0 32 608 26 199 13 288 10 163 61
2021/20222.664 347 388 21 30 430 5 395 92 283 5 63 605
2022/20233.486 366 93 28 230 350 655 4 576 976 29 115 64
2023/20241.668 82 111 73 86 65 160 160 355 17 40 230 289
2024/20255.284 38 718 371 170 1.185 404 110 202 522 693 314 557
2025/20264.413 705 596 2.648 464 0 0 0 0 0 0 0 0
Totale 22.088